Value Creation And Destruction: Dispersion Of Performance In Biotech IPOs The current biotech IPO market remains surprisingly strong and resilient. One of the characteristics of biotech IPO performance over the past eight years has been its dispersion, a feature that continues in the current environment. The author examines post-IPO value creation and destruction.